Validation of the Rhinitis Control Scoring System (RCSS)
NCT ID: NCT00967967
Last Updated: 2013-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
50 participants
INTERVENTIONAL
2009-03-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097
Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis
NCT06709079
Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)
NCT00834119
Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis
NCT05708157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mometasone furoate and desloratadine
Mometasone and desloratadine treatment
Medication Mometasone furoate and desloratadine
One month treatment with both drugs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medication Mometasone furoate and desloratadine
One month treatment with both drugs
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* seasonal allergic rhinitis
Exclusion Criteria
* nasal polyposis
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Louis-Philippe Boulet
Professeur
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louis-Philippe Boulet, MD
Role: PRINCIPAL_INVESTIGATOR
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut universitaire de cardiologie et de pneumologie de Québec
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Boulay ME, Boulet LP. The Rhinitis Control Scoring System: Development and validation. Am J Rhinol Allergy. 2016 Jan-Feb;30(1):54-9. doi: 10.2500/ajra.2016.30.4260.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CER 20389
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.